Hospital News and Research

RSS

Ochsner Health study highlights benefits of combination therapy for cardiovascular risks

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. "Chip" Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious Mayo Clinic Proceedings highlighting the comparative efficacy of lipid-lowering therapies for reducing cardiovascular risks and led by Maciej Banach, MD,PhD from Poland and leader of the International Lipid Expert Panel ( ILEP).

25 Mar 2025

Multi-modal imaging reveals complex brain alterations associated with autism spectrum disorder

Autism spectrum disorder (ASD) is a growing global concern, affecting approximately 2.8% of children in the United States and 0.7% in China. ASD is characterized by challenges in social interaction, communication difficulties, and repetitive behaviors, making early diagnosis critical for improving outcomes.

25 Mar 2025

Targeting PCSK9 and APOA4 for the treatment of TMAO-induced cholelithiasis

Cholesterol synthesis and gallstone formation are promoted by trimethylamine-N-oxide (TMAO), a derivative of trimethylamine, which is a metabolite of gut microbiota.

25 Mar 2025

CDC study identifies leading culprits of foodborne illness

Researchers from the CDC and Colorado School of Public Health estimate that seven major pathogens caused 9.9 million foodborne illnesses in the US in 2019. Norovirus led illness and hospitalization counts, while Salmonella caused the most deaths.

25 Mar 2025

Blocking an inflammatory receptor in the retinas of aging mice improves retinal health

A new research paper was published in Aging (Aging-US) on January 31, 2025, in Volume 17, Issue 2, titled "Cysteinyl leukotriene receptor 1 modulates retinal immune cells, vascularity and proteolytic activity in aged mice."

25 Mar 2025

Mapping the brain network behind generalized epilepsy

Frederic L.W.V.J. Schaper, MD, PhD, director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at Brigham and Women's Hospital and an instructor of neurology at Harvard Medical School, is the senior author of a paper published in Nature Communications, "A generalized epilepsy network derived from brain abnormalities and deep brain stimulation."

25 Mar 2025

Study shows artificial intelligence can improve intravenous nutrition for premature babies

Artificial intelligence can improve intravenous nutrition for premature babies, a Stanford Medicine study has shown.

25 Mar 2025

New study links metabolic defects to Dravet syndrome

New research from the University of Colorado Anschutz Medical Campus is the first to identify defects related to metabolism (how the body processes and uses energy) in lymphoblast cell lines (LCLs) derived from blood samples of children with Dravet syndrome.

25 Mar 2025

Optimizing naloxone kit distribution to prevent opioid deaths

A new study from University of Toronto Engineering researchers points to practical strategies to prevent deaths from opioid poisoning by optimizing the distribution of naloxone kits.

24 Mar 2025

New AI model predicts sepsis mortality in the ICU with high accuracy

Sepsis is one of the deadliest conditions in intensive care units (ICUs), triggered by the body's out-of-control response to infection.

24 Mar 2025

New brain circuit involved in motion sickness could help improve metabolic health

Motion sickness is a very common condition that affects about 1 in 3 people, but the brain circuits involved are largely unknown. In the current study published in Nature Metabolism, researchers at Baylor College of Medicine, the University of Texas Health Science Center at Houston and the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital describe a new brain circuit involved in motion sickness that also contributes to regulating body temperature and metabolic balance.

24 Mar 2025

Besifovir dipivoxil maleate offers comparable efficacy and improved safety for hepatitis B patients

Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer than six months are considered "chronic".

24 Mar 2025

Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors

B-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it can affect people of any age.

24 Mar 2025

Smell-based test taken at home could predict cognitive impairment in older adults

When it comes to early detection of cognitive impairment, a new study suggests that the nose knows. Researchers from Mass General Brigham developed olfactory tests-in which participants sniff odor labels that have been placed on a card-to assess people's ability to discriminate, identify and remember odors.

24 Mar 2025

Novel long-acting contraceptive implant can be delivered through tiny needles

Mass General Brigham and MIT investigators have developed a long-acting contraceptive implant that can be delivered through tiny needles to minimize patient discomfort and increase the likelihood of medication use.

24 Mar 2025

UZH researchers develop decoy molecules to restore immune defense

An immune system defect makes affected individuals vulnerable to severe viral diseases such as influenza or COVID-19. It is caused by the body's own antibodies, which inhibit important defense proteins known as type I interferons.

24 Mar 2025

New MIT method promises less painful drug injections with tiny crystals

MIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a suspension of tiny crystals.

24 Mar 2025

Simple urine test may spare kidney cancer patients from invasive scans

A simple urine test could accurately show the recurrence of kidney cancer at an early stage, potentially sparing patients invasive scans and enabling faster access to treatment, new research has shown.

24 Mar 2025

Epstein-Barr virus triggers inflammatory cell death in ulcerative colitis

Ulcerative colitis (UC) is a chronic, relapsing disease that causes painful inflammation and ulcers in the colon.

24 Mar 2025

Researchers develop tool to enhance NK cells against cancer

A team of researchers from the Hospital del Mar Research Institute, the Universitat Autònoma de Barcelona and the Pompeu Fabra University has developed a new tool that allows modifying these NK cells to make them immune to the tumor’s defense mechanism.

24 Mar 2025

Hospital News and Research

Ochsner Health study highlights benefits of combination therapy for cardiovascular risks

Multi-modal imaging reveals complex brain alterations associated with autism spectrum disorder

Targeting PCSK9 and APOA4 for the treatment of TMAO-induced cholelithiasis

CDC study identifies leading culprits of foodborne illness

Blocking an inflammatory receptor in the retinas of aging mice improves retinal health

Mapping the brain network behind generalized epilepsy

Study shows artificial intelligence can improve intravenous nutrition for premature babies

New study links metabolic defects to Dravet syndrome

Optimizing naloxone kit distribution to prevent opioid deaths

New AI model predicts sepsis mortality in the ICU with high accuracy

New brain circuit involved in motion sickness could help improve metabolic health

Besifovir dipivoxil maleate offers comparable efficacy and improved safety for hepatitis B patients

Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumors

Smell-based test taken at home could predict cognitive impairment in older adults

Novel long-acting contraceptive implant can be delivered through tiny needles

UZH researchers develop decoy molecules to restore immune defense

New MIT method promises less painful drug injections with tiny crystals

Simple urine test may spare kidney cancer patients from invasive scans

Epstein-Barr virus triggers inflammatory cell death in ulcerative colitis

Researchers develop tool to enhance NK cells against cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News